Shares of Ubtech Robotics tumbled 8.9% to $10.95 on July 6, erasing much of the gains ignited days earlier by a double shot of good news: regulatory approval for a plan to convert restricted domestic shares into tradable Hong Kong-listed stock, and the announcement of more than 13,000 pre-orders for its new consumer companion robot. The pullback raises a pointed question — whether this is healthy profit-taking or a market verdict on execution risk.
• A Flashy Order Number Built on Refundable Deposits
As of the June 30 launch event, cumulative orders for the U1 Series had surpassed 13,361 units — a figure that dwarfs the 1,079 humanoids it sold in all of 2025. But the fine print matters: the 3,000-yuan (~$440) fully refundable deposit mechanism significantly dilutes the substance of these pre-sale figures. Until deliveries begin — shipments are scheduled to start September 16, with full delivery expected by year-end — the backlog remains aspirational, not revenue.
• The Company Has Never Turned a Profit
Ubtech has suffered losses for six consecutive years, with cumulative losses exceeding 5.6 billion yuan (~$826 million).
Revenue jumped 53% in 2025 to 2.0 billion yuan, while gross margin expanded from 28.7% to 37.7%, but Bank of America expects the loss to narrow to ¥209 million in 2026 and flip to profit only in 2027. Investors are being asked to price in a turnaround that hasn't arrived yet.
• Unlocking Shares Could Add Selling Pressure
Ubtech secured CSRC approval to complete filing for H-share full circulation of over 5.45 million domestic shares. Full circulation means previously locked-up insider shares become tradable in Hong Kong, which can boost liquidity but also opens the door to founder or early-investor selling — a dilution risk the market appeared to reprice on Monday.
• A Fierce Competitive Race Looms
Rival Unitree Robotics delivered more than 5,500 humanoids in 2025 and turned profitable in the same year — a milestone Ubtech has yet to reach. Meanwhile, Tesla has shut down Model S and X production lines at Fremont to make way for initial Optimus production, with an estimated 5,000 units expected between July and August 2026. Ubtech must ramp from ~1,000 annual deliveries to 20,000 units this year across consumer and industrial lines — output that alone would surpass last year's global total. That is an enormous manufacturing bet for a company still burning cash. BofA raised its price target to HK$162 and boosted revenue forecasts 15%–20%, but the stock's sharp reversal shows the market wants delivered robots, not deposits.